Join us for an exclusive one-hour class with our special guest, Dr. Richard Amerling, a renowned nephrologist with decades of experience and past President of the AAPS, as he shares eye-opening insights about the cholesterol and statin controversy.

Read about this class:

In a revealing Masterclass, Dr. Richard Amerling, a retired academic nephrologist and former key opinion leader for pharmaceutical companies, shared his journey from being a staunch advocate of prescription drugs to becoming a leader in the deprescribing movement. His insights into the inner workings of Big Pharma, particularly regarding statins, are both eye-opening and alarming. Here are the key takeaways from his presentation.

---

From Pharma Enthusiast to Skeptic

Dr. Amerling began his career as a passionate academic nephrologist, working at Beth Israel Medical Center in New York and later teaching at Saint George’s University in Grenada. Early in his career, he was an enthusiastic prescriber of pharmaceutical drugs, often attending industry-sponsored events and even becoming a key opinion leader for companies like Amgen and Genzyme. However, over time, he grew disillusioned with the pharmaceutical industry, witnessing how it manipulated science for profit rather than patient care.

---

The Big Pharma Playbook: Profits Over Patients

Dr. Amerling outlined the key strategies Big Pharma uses to maximize profits, often at the expense of patient health:

1. Inventing Diseases: Pharma creates conditions like hypercholesterolemia (high cholesterol) to sell drugs. Cholesterol, a vital substance produced by the body, was rebranded as a disease simply because Pharma had a "cure" (statins).

2. Expanding Indications: Companies broaden the use of their drugs by lowering thresholds for what’s considered "healthy." For example, the definition of "normal" cholesterol and blood pressure levels has been repeatedly lowered, turning more people into patients.

3. Manipulating Studies: Pharma designs, writes, and publishes studies that exaggerate benefits and downplay side effects. Unfavorable studies are buried, and only positive results are published in top medical journals.

4. Funding Guidelines: Pharma heavily influences medical guidelines by funding guideline committees. These committees, often composed of industry-paid experts, recommend widespread use of their products.

5. Controlling Education: Big Pharma funds medical education, ensuring that doctors are trained to prescribe their drugs. Professional societies, like the American Society of Nephrology, rely on Pharma money, creating a conflict of interest.

---

The Statin Scam: A Case Study in Pharma Manipulation

Dr. Amerling used statins, cholesterol-lowering drugs like Lipitor and Crestor, as a prime example of Pharma’s deceptive practices:

1. The Cholesterol Myth

- The idea that high cholesterol causes heart disease is based on flawed science, particularly the work of Ancel Keys, who cherry-picked data to support his low-fat diet hypothesis. Countries like France and Switzerland, with high-fat diets and low heart disease rates, were excluded from his studies.

- Cholesterol is essential for cellular function, hormone production, and brain health. Statins, which block cholesterol production, can have severe side effects, including muscle damage, heart failure, and dementia.

2. Relative Risk vs. Absolute Risk

- Pharma uses relative risk reduction to exaggerate the benefits of statins. For example, if a study shows a 1% reduction in heart attacks (from 3% to 2%), Pharma claims a 33% relative risk reduction, making the drug appear far more effective than it is.

- In reality, the absolute risk reduction is minimal, often less than 1%, making the benefits clinically insignificant.

3. Hidden Side Effects

- Statins deplete coenzyme Q10, a vital nutrient for mitochondrial energy production, leading to muscle weakness and heart failure.

- They also interfere with brain cholesterol production, contributing to brain fog and dementia. Studies show that stopping statins can reverse these symptoms in many patients.

4. The Diet-Heart Hypothesis

- The belief that saturated fat raises cholesterol and causes heart disease is a myth. The standard American diet, high in vegetable oils, sugar, and processed foods, is the real culprit behind metabolic syndrome, type 2 diabetes, and heart disease.

---

The Deprescribing Movement: Stopping Harmful Drugs

Dr. Amerling is now a leading advocate for deprescribing, the practice of stopping unnecessary or harmful medications. He emphasizes that:

- Statins should be the first drugs to deprescribe, as they offer no meaningful benefit and carry significant risks.

- Patients should ask their doctors critical questions before starting any medication, such as:

- What is my baseline risk of disease?

- What is the absolute risk reduction of this drug?

- What are the potential side effects?

- Are there dietary or lifestyle changes that could reduce my risk?

---

Reversing Disease Through Lifestyle Changes

Dr. Amerling believes that most chronic diseases, including heart disease and type 2 diabetes, are reversible through lifestyle changes:

- Keto Diet: A low-carb, high-fat diet can reverse metabolic syndrome and improve overall health.

- Intermittent Fasting: Fasting promotes autophagy, the body’s natural process of cellular repair, and helps regulate blood sugar levels.

- Avoiding Processed Foods: Eliminating vegetable oils, sugar, and processed foods can reduce inflammation and improve cardiovascular health.

---

Key Takeaways:

- Big Pharma prioritizes profits over patients, inventing diseases, manipulating studies, and controlling medical guidelines to sell drugs.

- Statins are largely ineffective and carry significant risks, including muscle damage, heart failure, and dementia.

- Deprescribing unnecessary medications, particularly statins, can improve patient outcomes.

- Lifestyle changes, such as a keto diet and intermittent fasting, are more effective than drugs for reversing chronic diseases.

Dr. Amerling’s journey from Pharma insider to deprescribing advocate is a powerful reminder that true health comes from understanding the root causes of disease, not from relying on profit-driven pharmaceutical solutions. His call to question the status quo and prioritize patient well-being over corporate profits is a message that resonates deeply in today’s healthcare landscape.